Marine-Derived Pharmaceuticals Market

Marine-Derived Pharmaceuticals Market: Overview

Marine is source to several bioactive agents for utilization for their therapeutic potential. The drive for marine-derived pharmaceuticals market stems from the market potential of marine-derived secondary metabolites. Key metabolites used in the design and development of drugs include halogenated terpenes, steroids and sterols, and polyphenols. Researchers have also seen considerable potential of marine proteins and lipids for human health. Strides made in biotechnology in industrialized as well as developing countries have brought to the fore several marine sources for the pharmaceutical industry.

A number of marine-derived pharmaceuticals have shown potential in the management of viral diseases, chronic pain, and triglyceride level in blood. The massive biodiversity of marine environment is attributed to its striking novelty, complexity, and diversity, thereby opening a vast canvas to the discovery of new therapeutic agents.

Marine-Derived Pharmaceuticals Market: Key Trends

The demand for efficacious pharmaceutical products around the world has increased the proportion of marketed drugs extracted from natural sources. This is prominent in cancer, inflammatory diseases, neurodegenerative diseases, and viral and fungal infections. Rise in ethnobotanical preparations has been fuelled some of the remarkable automated pharmacological bioassays. A growing number of novel marine natural products since the last decade has boosted the marine-derived pharmaceuticals market. Polyunsaturated fatty acids like eicosapentaenoic acid and docosahexaenoic are some of the extensively end-use applications in the marine-derived pharmaceuticals market.

Marine-Derived Pharmaceuticals Market: Key Developments

The increasing trend of bioprospecting for new marine products has steadily been broadening the growth avenues in the marine-derived pharmaceuticals market. New molecular biology approaches have come to the fore, and have paved way to exploitation of the whole biochemical potential of marine invertebrates. In this regard, metagenome analysis has attracted a groundswell of attention.

A prominent trend is widespread medicinal need for new antitumor drugs. In recent years, the marine-derived pharmaceuticals market has witnessed strides in rising industry efforts for novel oncotherapeutics. A number of marine bioactives have been seeing attention for in vivo applications. In coming years, their synthetic derivatives will be intensely researched, expanding the outlook in the marine-derived pharmaceuticals market.